-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732. Clinical Allogeneic Transplantation: Results: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, antibodies, Biological, CRS, HSCs, Leukemia, multiple myeloma, bone marrow, CML, Diseases, Lymphoma (any), Non-Biological, Combinations, Elderly, Mantle Cell Lymphoma, Therapies, Adverse Events, chemotherapy, MDS, Non-Hodgkin Lymphoma, Pediatric, DLBCL, Technology and Procedures, Young Adult, Cell Lineage, immunotherapy, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, flow cytometry, transplantation, TKI, molecular testing, stem cells
Monday, December 7, 2020: 7:00 AM-3:30 PM

Arnon Nagler, MD1, Myriam Labopin, MD2*, Mohamed Houhou3*, Mahmoud Aljurf4, Ashrafsadat Mousavi5*, Rose-Marie Hamladji, MD, PhD6*, Mohsen Alzahrani7*, Sergey N. Bondarenko8*, Mutlu Arat, MD9, Emanuele Angelucci, MD10, Yener Koc11*, Zafer Gulbas, MD12*, Simona Sica, MD, PhD13*, Jean-Henri Bourhis14, Jonathan Canaani, MD15, Eolia Brissot, MD, PhD16*, Sebastian Giebel Sr.17* and Mohamad Mohty, MD, PhD18

1Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel
2EBMT Paris study office; Department of Haematology,, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France
3ALWP of the EBMT Paris office, Paris, France
4King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
5Shariati Hospital ,Hematology-Oncology and BMT Research, Tehran, Iran (Islamic Republic of)
6Service Hématologie Greffe de Moëlle, Centre Pierre Et Marie Curie, Alger, Algeria
7King Abdulaziz Medical City, Riyadh, Saudi Arabia
8Raisa Gorbacheva Memorial Institute of Children Oncology Hematology and Transplantation, First Pavlov State Medical University, Sant-Petersburg, Russian Federation
9Hematopoietic Stem Cell Transplantation Unit, Sisli Florence Nightingale Hospital,, Istanbul, Turkey
10Department of Haematology II, Genova Ospedale San Martino, Genova, Italy
11Medicana International, Istanbul, Turkey
12Anadolu Medical Center Hospital, Bone Marrow Transplantation Department, Kocaeli, Turkey
13Fondazione Policlinico A. Gemelli IRCCS, Roma, Italy; Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy, Roma, Italy
14Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France
15Hematology Division, Sheba Medical Center, Givatayim, Israel
16Hematology Department, Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, Paris, France
17Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
18Saint Antoine Hospital, Paris, France

Guru Subramanian Guru Murthy, MD1*, Soyoung Kim2,3*, Zhen-Huan Hu, MPH4*, Noel Estrada-Merly, MS5*, Ryotaro Nakamura, M.D.6, Betul Oran, MD, MS7, Bart L. Scott, MD8, Ronald Sobecks, MD9 and Wael Saber, MD, MS10

1Medical College of Wisconsin, Milwaukee, WI
2Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI
4CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
5CIBMTR (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin, Milwaukee, WI
6Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
7Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX
8Fred Hutchinson Cancer Research Center, Seattle, WA
9Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
10CIBMTR, Medical College of Wisconsin, Milwaukee, WI

Geoffrey L Uy, MD1, Laura F. Newell, MD2, Tara Lin, MD3, Stuart L. Goldberg4, Matthew J. Wieduwilt, MD, PhD5, Robert J. Ryan6*, Stefan Faderl7 and Jeffrey E. Lancet, MD8

1Washington University School of Medicine, St. Louis, MO
2Oregon Health & Science University, Portland, OR
3University of Kansas Medical Center, Kansas City, KS
4John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
5University of California – San Diego Moores Cancer Center, La Jolla, CA
6Jazz Pharmaceuticals, Philadelphia, PA
7Jazz Pharmaceuticals, Palo Alto, CA
8H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Armin Ghobadi, MD1, Kahee A Mohammed, MD, MPH1, Rawan Faramand, MD2, Hagop M. Kantarjian, MD3, Elias Jabbour, MD4, Nicholas J. Short, MD4, Feng Gao, MD, PhD, MPH1*, Geoffrey L Uy, MD1, Peter Westervelt, MD, PhD1, John F. DiPersio, MD1, Richard E. Champlin, MD5, Farhad Ravandi, MBBS4 and Partow Kebriaei, MD5

1Washington University School of Medicine, Saint Louis, MO
2Moffitt Cancer Center, University of South Florida, Tampa, FL
3University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Firoozeh Sahebi1*, Dirk-Jan Eikema2*, Linda Koster3*, Nicolaus Kröger4*, Ellen Meijer5*, Goda Choi6, Montserrat Rovira7*, Yener Koc8*, Emanuele Angelucci9*, Didier Blaise, MD10, Corrado Tarella11*, Andrew McDonald12*, Concepcion Herrera Arroyo13*, Noel Milpied14*, Luca Castagna15*, Friedrich Stoelzel, PD, MD16, Jaime Sanz Caballer, MD, PhD17*, Johanna Tischer18*, Fabio Ciceri19*, David Valcarcel20, Luigi Rigacci21*, Patrick J Hayden, MD22, Meral Beksac, MD23, Ibrahim Yakoub-Agha24 and Stefan Schonland25*

1City of Hope, Duarte, CA
2EBMT Statistical Unit, Leiden, Netherlands
3EBMT Data Office, Leiden, Netherlands
4University Hospital Eppendorf, Hamburg, Germany
5VU University Medical Center, Amsterdam, Netherlands
6University of Groningen, University Medical Center Groningen, Groningen, Netherlands
7Hospital Clinic, Dept. of Hematology, IDIBAPS, Barcelona, Spain, Barcelona, Spain
8Medicana International, Istanbul, Turkey
9Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
10Institut Paoli Calmettes, Marseille, France
11European Institute of Oncology, Milan, Italy
12Netcare Pretoria East Hospital, Pretoria, South Africa
13Hospital Reina Sofia, Cordoba, Spain
14CHU Bordeaux, Pessac, France
15Transplantation Unit, Department of Oncology and Haematology, Instituto Clinico Humanitas, Milan, Italy
16Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
17Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Valencia, Spain
18LMU, Department of Internal Medicine III, University Hospital of Munich-Grosshadern, Munich, -, Germany
19Ospedale San Raffaele s.r.l., Milan, Italy
20Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Barcelona, Spain
21Ospedale S. Camillo-Forlanini, Rome, Italy
22Department of Haematology, St. James's Hospital, Dublin, Ireland
23Ankara University School of Medicine, Department of Hematology, Ankara, Turkey
24Univ Lille, CHU de Lille, INFINITE, INSERM U1286, 59000 Lille, LILLE, France
25University Hospital Heidelberg, Heidelberg, Germany

Evan C. Chen, MD1, Shuli Li, PhD2*, Ann-Kathrin Eisfeld, MD3, Marlise R Luskin, MD, MS4, Alice S. Mims, MD5, Daniel Jones, MD, PhD5, Joseph H. Antin, MD4, Corey Cutler, MD, MPH, FRCPC 4, John Koreth, MBBS, DPhil4, Vincent T. Ho, MD4*, Mahasweta Gooptu, MD4, Rizwan Romee, MD4, Areej El-Jawahri, MD6, Steven L. McAfee, MD6*, Zachariah Defilipp, MD6, Robert J. Soiffer, MD4, Yi-Bin Chen, MD6 and Amir T. Fathi7

1Massachusetts General Hospital, Brookline, MA
2Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA
3Division of Hematology, The Ohio State University, Columbus, OH
4Dana-Farber Cancer Institute, Department of Hematologic Malignancies and Harvard Medical School, Boston, MA
5The Ohio State University Comprehensive Cancer Center, Columbus, OH
6Massachusetts General Hospital, Blood and Marrow Transplant Program, Boston, MA
7Leukemia Center, Massachusetts General Hospital, Center for Leukemia, Cambridge, MA

Nicholas P. Tschernia, MD1, Vaibhav Kumar, MBBS, MS1, Dominic T. Moore, MPH, MS1*, Benjamin G. Vincent, MD1, Callie C. Coombs, MD1, Hendrik Van Deventer, MD1*, Matthew C. Foster, MD1*, Amy E. DeZern, MD2, Leo Luznik, MD3, Marcie L. Riches, MD, MS1, Jonathan S. Serody, MD1, Ivana Gojo, MD3 and Joshua F. Zeidner, MD1

1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
2Sidney Kimmel Comprehensive Cancer Center, 1650, Baltimore, MD
3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Nicole Karras, MD1*, Ni-Chun Tsai, MS2*, Ahmed Tahoun, MD3*, Saloomeh Mokhtari4, Haris Ali, MD5, Shukaib Arslan, MD5, Anna B Pawlowska, MD1, Chatchada Karanes6, Joseph Rosenthal, MD, MS5, David S Snyder, MD5, Stephen J. Forman, MD5, Ryotaro Nakamura, M.D.5 and Monzr M. Al Malki, MD5

1Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
2Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
3Shared Resources-Clinical Trial Office, City of Hope National Medical Center, Duarte, CA
4Department of Clinical Translational Project Development, City of Hope, Duarte, CA, City of Hope National Medical Center, Duarte, CA
5Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
6Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA

Mindy Hsiao, MD1, Preet M. Chaudhary, MD, PhD2 and George Yaghmour, MD3

1LAC-USC Hematology Fellowship, Los Angeles, CA
2Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA
3USC Norris Cancer Hospital, Los Angeles, CA

Reyes María Martín-Rojas, MD1*, Gillen Oarbeascoa, MD1,2*, Rebeca Bailén, MD1,2*, Ignacio Gómez-Centurión, MD1,2*, Luis Miguel Juarez, MD1,2*, Nieves Dorado, MD1,2*, Carolina Martínez-Laperche, PhD1,2*, Ana Pérez-Corral, MD, PhD1,2*, Ismael Buño, PhD1,2*, Javier Anguita, MD, PhD1,2*, Jose L. Diez-Martin, MD, PhD1,2,3 and Mi Kwon, MD, PhD1,2*

1Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
2Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain
3Universidad Complutense de Madrid, Madrid, Spain

Pietro R Di Ciaccio, BA/LLB MBBS FRACP FRCPA1,2, David Ritchie, MB ChB, PhD, FRACP, FRCPA3,4,5, Glen A Kennedy, MBBS FRACP FRCPA6,7*, Sam Milliken, MBBS, FRACP, FRCPA2*, Duncan Purtill, MBBS, FRCPA, FRACP8,9*, David Gottlieb, MBBS, MD, FRACP, FRCPA10,11*, Travis Perera, MB ChB, FRACP, FRCPA12*, David T Yeung, BSc, PhD, FRACP, FRCPA, MBBS13,14, Stephen R Larsen, MBBS PhD FRACP FRCPA15,16, Richard Doocey, MB ChB, FRACP, FRCPA17, Matthew Greenwood, MBBS, FRACP, FRCPA15,18*, Simon Durrant, MBBS FRCP FRCPath19,20, Anne-Marie Watson, FRACP, FRCPA, MBBS21, Andrew Butler, MB ChB(Edin), MRCP, MRCPath22*, Amit Khot, MBBS, MD, MRCP, FRCPath, FRACP23,24, Cameron Curley, MBBS, FRACP, FRCPA6* and Nada Hamad, MBBS, BSc, MSc, FRACP FRCPA25,26

1University of New South Wales, Sydney, Australia
2Department of Haematology and Bone Marrow Transplantation, St Vincent's Hospital, Sydney, Australia
3Royal Melbourne Hospital, Melbourne, VIC, Australia
4Department of Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
5The University of Melbourne, Parkville, VIC, Australia
6Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia
7School of Medicine, University of Queensland, St Lucia, QLD, Australia
8University of Western Australia, Perth, Australia
9Department of Haematology, Fiona Stanley Hospital, Perth, Australia
10Department of Haematology and Bone Marrow Transplantation, Westmead Hospital, Sydney, NSW, Australia
11Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
12Wellington Blood and Cancer Centre, Wellington, New Zealand
13Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
14Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia
15University of Sydney, Sydney, NSW, Australia
16Institute of Haematology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
17Department of Haematology, Auckland City Hospital, Auckland, New Zealand
18Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia
19Wesley Clinic Research Centre Stem Cell Transplant Programme, Wesley Hospital, Brisbane, QLD, Australia
20University of Queensland, Brisbane, QLD, Australia
21Department of Haematology, Liverpool Hospital, Sydney, NSW, Australia
22Department of Haematology, Canterbury District Health Board, Christchurch, New Zealand
23Department of Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia
24Royal Melbourne Hospital, Melbourne, Australia
25Faculty of Medicine, University of New South Wales, Sydney, Australia
26Department of Haematology, St Vincent's Hospital, Sydney, Australia

Raynier Devillier1,2,3*, Jacques-Emmanuel Galimard4*, Myriam Labopin, MD4*, Didier Blaise, MD1, Emanuele Angelucci5*, Luca Castagna6*, Jiri Pavlu, MD, MRCP, FRCPath7, Gerard Socie, MD, PhD8, Massimo Martino9*, Friedrich Stoelzel, PD, MD10, Gesine Bug11*, Yves Chalandon, MD12, Benedetto Bruno, MD13*, Victoria Potter, MBBS, BSc, FRACP, FRCPA14*, Eolia Brissot, MD, PhD15*, Bipin N. Savani, MD16, Arnon Nagler, MD4,17 and Mohamad Mohty, MD, PhD4,18

1Institut Paoli Calmettes, Marseille, France
2CRCM / INSERM U1068, Marseille, France
3Aix Marseille University, Medicine Faculty, Marseille, France
4EBMT ALWP, Paris, France
5Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
6Humanitas Cancer Center, Rozzano (Milan), Italy
7Department of Haematology, Hammersmith Hospital, Imperial College, London, United Kingdom
8Department of Hematology Transplantation, Saint-Louis Hospital, AP-HP, Paris, France
9Division of Stem Cell Transplantation and Cellular Therapies, Grande Ospedale Metropolitano BMM, Reggio Calabria, Italy
10Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
11Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany
12Geneva University Hospitals, Geneva, Switzerland
13SSCVD Trapianto di Cellule Staminali, AOU Città della Salute e della Scienza di Torino, Torino, Italy
14Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
15Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Sorbonne Université, INSERM UMRs 938, Paris, France, Paris, France
16Department of Medicine, Division of Hematology-Oncology, Vanderbilt University, Brentwood, TN
17Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel
18Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France

Yiwen Wang1, Weiyin Zhou, MS2,3*, Junke Wang, MS1*, Ezgi Karaesmen, PhD1, Hancong Tang, MS1*, Philip L. McCarthy, MD4, Marcelo C. Pasquini, MD, MS5, Youjin Wang, PhD, BPharm6*, Lisa J. McReynolds, MD, PhD7, Hormuzd Katki, PhD8*, Mitchell Machiela, PhD9*, Meredith Yeager, PhD10*, Loreall Pooler, MS11*, Xin Sheng, MS12*, Christopher Haiman, ScD13*, David Van Den Berg, PhD14*, Stephen R. Spellman, MS15*, Tao Wang, PhD16*, Michelle Kuxhausen, MS17*, Stephen J. Chanock, MD18*, Stephanie J. Lee, MD, MPH15,19, Alyssa I. Clay-Gilmour, PhD20, Theresa E. Hahn, PhD21, Shahinaz M Gadalla, MD, PhD18 and Lara E. Sucheston-Campbell, PhD, MS1,22

1College of Pharmacy, The Ohio State University, Columbus, OH
2Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
3Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD
4Roswell Park Cancer Institute, Buffalo, NY
5CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
6Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
7NCI, National Institutes of Health, Bethesda, MD
8NCI, Rockville, MD
9National Cancer Institute, Rockville, MD
10National Cancer Institute, Bethesda, MD
11Department of Preventive Medicine, University of Southern California, Los Angeles, CA
12University of Southern California, Keck School of Medicine of USC, Los Angeles, CA
13Center for Genetic Epidemiology, Department of Preventive Medicine, University of Southern California, Los Angeles, CA
14Preventive Medicine, University of Southern California, Keck School of Medicine of USC, Los Angeles, CA
15CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
16Medical College of Wisconsin, Milwaukee, WI
17Center for International Blood and Marrow Transplant Research, Minneapolis, MN
18Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
19Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
20Arnold School of Public Health- Department of Epidemiology & Biostatistics, University of South Carolina, Greenville, SC
21Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
22College of Veterinary Medicine, Cancer Prevention & Control, Columbus, OH

Salman Otoukesh, MD1*, Hany Elmariah, MD, MS2, Dongyun Yang, PhD3*, Sally Mokhtari, PhD4, Madiha Siraj5*, Haris Ali, MD1, Krishnakar Mogili2*, Shukaib Arslan, MD1, Taiga Nishihori, MD6, Chatchada Karanes, MD1*, Joseph Pidala, MD2, Ryotaro Nakamura, M.D.1, Claudio Anasetti, MD2, Stephen J. Forman, MD1, Monzr M. Al Malki, MD1 and Nelli Bejanyan, MD2

1Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
4Department of Clinical Translational Project Development, City of Hope, Duarte, CA, City of Hope National Medical Center, Duarte, CA
5University of South Florida, Tampa/St. Petersburg, FL
6Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Audrey Françoise Petit1*, Dirk-Jan Eikema2*, Alexey Maschan, MD3,4, Dalila Adjaoud, MD5*, Aleksander Kulagin6*, Alessandro Rambaldi, MD7, Franca Fagioli, MD8*, Laimonas Griškevičius, MD, PhD9*, John A Snowden, BSc (Hons), MBChB, MD, FRCP, FRCPath10, Jan-Erik Johansson, MD, PhD11*, Jean-Hugues Dalle, MD, PhD12, Jenny Byrne, MD, PhD13*, Antonio Risitano, MD, PhD14,15 and Regis Peffault De Latour, MD, PhD16,17*

1Pediatric hematology and oncology, CHU de Grenoble, Grenoble Cedex, France
2EBMT Statistical Unit, Leiden, Netherlands
3Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation, Moscow, Russian Federation
4"Dmitry Rogachev National Medical Research Centre for Pediatric Hematology, Oncology and Immunology", Moscow, Russian Federation
5hemato oncologie pédiatrique, CHU de Grenoble, Grenoble, France
6RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation
7Department of Oncology and Hematology University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
8Division of Pediatric Onco-hematology, Regina Margherita-S. Anna Hospital, Turin, Italy
9Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
10Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom
11Sahlgrenska University Hospital, Gothenburg, SWE
12Pediatric Hematology Department, Robert Debre Hospital, AP-HP, Paris, France
13Centre for Clinical Haematology, Nottingham University Hospitals Trust, Nottingham, ENG, United Kingdom
14Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT), Leiden, Netherlands
15Department of Clinical Medicine and Surgery, University of Naples, Naples, Italy
16French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Saint Louis Hospital and University Paris Diderot, Paris, France
17French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Assistance Publique – Hôpitaux de Paris, Université de Paris, Paris, France

Akash Mukherjee1, Denái R. Milton, MS2*, Elias Jabbour, MD3, Naval Daver, MD4, Alison Gulbis5*, Celina Ledesma1,6*, Marina Konopleva, MD, PhD7, Courtney D. DiNardo, MD, MSc8, Farhad Ravandi, MBBS9, Tapan M. Kadia, MD8, Gheath Alatrash1, Amin M. Alousi, MD10, May Daher11, David Marin6, Amanda L. Olson11, Betul Oran, MD, MS12, Partow Kebriaei, MD6, Neeraj Saini, MD6, Samer A. Srour, MD, MS11, Uday R. Popat, MD11, Jin S. Im11, Rohtesh Mehta1*, Gabriela Rondon6, Hagop M. Kantarjian, MD3, Richard E. Champlin, MD11 and Issa F. Khouri, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
2Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Pharmacy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
10Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX
11Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
12Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX

Justin Jiang, BS1, Audrey M. Sigmund, MD2, Qiuhong Zhao, MS2*, Patrick Elder, MS2*, Don M. Benson Jr., MD, PhD2, Ashley Rosko, MD2, Maria Chaudhry, MD2, Naresh Bumma, MD2, Abdullah Khan, MBBS, MSc2, Srinivas Devarakonda, MD2, Sumithira Vasu, MD, MBBS2, Samantha Jaglowski, MD, MPH2, Basem M. William, MD, MRCP2, Alice S. Mims, MD3, Hannah Choe, MD2, Karilyn Larkin, MD2, Jonathan E. Brammer, MD2, Sarah A Wall, MD2, Nicole Grieselhuber, MD, PhD2*, Ayman Saad, MD, MSc2*, Sam Penza, MD2, Yvonne A. Efebera, MD, MPH2 and Nidhi Sharma, PhD2*

1The Ohio State College of Medicine, Columbus, OH
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Sanghee Hong, MD1, Lisa Rybicki, MS2*, Linda McLellan, LISW2*, Jane Dabney, LISW-S2*, Aaron T. Gerds, MD, MS2, Seth J Rotz, MD2*, Matt Kalaycio, MD2, Rabi Hanna, MD2, Betty K. Hamilton, MD3, Navneet S. Majhail, MD, MS3 and Ronald Sobecks, MD4

1University Hospitals/ Case Western Reserve University, Cleveland, OH
2Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Hematology and Medical Oncology, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
4Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH

Audrey M. Sigmund, MD1, Qiuhong Zhao, MS1*, Justin Jiang, BS2, Patrick Elder, MS1*, Don M. Benson Jr., MD, PhD1, Ashley Rosko, MD1, Maria Chaudhry, MD1, Naresh Bumma, MD1, Abdullah Khan, MBBS, MSc1, Srinivas Devarakonda, MD1, Sumithira Vasu, MD, MBBS1, Samantha Jaglowski, MD, MPH1, Basem M. William, MD, MRCP1, Alice S. Mims, MD3, Hannah Choe, MD1, Karilyn Larkin, MD1, Jonathan E Brammer, MD1, Sarah A Wall, MD1, Nicole Grieselhuber, MD, PhD1*, Ayman Saad, MD1, Sam Penza, MD1, Yvonne A. Efebera, MD, MPH1 and Nidhi Sharma, PhD1*

1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
2The Ohio State College of Medicine, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Pietro R Di Ciaccio, BA/LLB MBBS FRACP FRCPA1,2, Matthew Greenwood, MBBS, FRACP, FRCPA3,4*, Glen A Kennedy, MBBS FRACP FRCPA5,6*, Sam Milliken, MBBS, FRACP, FRCPA2*, David Gottlieb, MBBS, MD, FRACP, FRCPA7,8*, David Ritchie, MB ChB, PhD, FRACP, FRCPA9,10, Duncan Purtill, MBBS, FRCPA, FRACP11,12,13*, Stephen R Larsen, MBBS PhD FRACP FRCPA14, Andrew Spencer15,16, Travis Perera, MB ChB, FRACP, FRCPA17*, David T Yeung, BSc, PhD, FRACP, FRCPA, MBBS18,19, Simon Durrant, MBBS FRCP FRCPath20,21, Andrew Butler, MB ChB(Edin), MRCP, MRCPath22*, Anne-Marie Watson, FRACP, FRCPA, MBBS23, Hock Choong Lai, MBBS, FRACP, FRCPA24, Richard Doocey, MB ChB, FRACP, FRCPA25, Hugh J. Goodman, FRACP26, Ian H. Kerridge, FRACP FRCPA MPhil BA27,28*, Christopher Arthur3,28, Cameron Curley, MBBS, FRACP, FRCPA5*, Caroline Stewart5*, Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA4,7*, Jennifer Collins29*, Julian Cooney, FRACP, FRCPA, MBBS,30 and Nada Hamad, MBBS, BSc, MSc, FRACP FRCPA31,32

1University of New South Wales, Sydney, Australia
2Department of Haematology and Bone Marrow Transplantation, St Vincent's Hospital, Sydney, Australia
3Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia
4University of Sydney, Sydney, NSW, Australia
5Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia
6School of Medicine, University of Queensland, St Lucia, QLD, Australia
7Department of Haematology and Bone Marrow Transplantation, Westmead Hospital, Sydney, NSW, Australia
8Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
9The University of Melbourne, Parkville, VIC, Australia
10Haematology Department, Royal Melbourne Hospital, Melbourne, VIC, Australia
11University of Western Australia, Perth, Australia
12PathWest Laboratory Medicine WA, Perth, Australia
13Department of Haematology, Fiona Stanley Hospital, Perth, Australia
14Institute of Haematology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
15Malignant Haematology & Stem Cell Transplantation Service, The Alfred Hospital, Melbourne, VIC, Australia
16Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia
17Wellington Blood and Cancer Centre, Wellington, New Zealand
18Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia
19Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
20Wesley Clinic Research Centre Stem Cell Transplant Programme, Wesley Hospital, Brisbane, QLD, Australia
21University of Queensland, Brisbane, QLD, Australia
22Department of Haematology, Canterbury District Health Board, Christchurch, New Zealand
23Department of Haematology, Liverpool Hospital, Sydney, NSW, Australia
24Department of Haematology, Townsville Hospital, Townsville, Australia
25Department of Haematology, Auckland City Hospital, Auckland, New Zealand
26Department of Haematology, Waikato Hospital, Hamilton, New Zealand
27Department of Haematology, Royal North Shore Hospital, Sydney, Australia
28University of Sydney, Sydney, Australia
29Department of Haematology, Royal Melbourne Hospital, Melbourne, NSW, Australia
30Department of Haematology, Fiona Stanley Hospital, Perth, WA, Australia
31Department of Haematology, St Vincent's Hospital, Sydney, Australia
32Faculty of Medicine, University of New South Wales, Sydney, Australia

Xavier A Andrade-Gonzalez, MD1*, Ayalew Tefferi, MD1, Animesh Pardanani, MBBS, PhD1, Naseema Gangat, MBBS1, Mrinal M. Patnaik, MD, MBBS1, Jeanne M. Palmer, Md2, Mohamed A. Kharfan-Dabaja, MD, MBA3, Mark Litzow, MD1, Mithun Vinod Shah, MD, PhD1, William J Hogan, MB, BCh4 and Hassan B. Alkhateeb, MD1*

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
3Mayo Clinic, Jacksonville, FL
4Mayo Clinic Rochester, Division of Hematology, Rochester, MN

Justin N. Malinou, MD1, Hanan Alkhaldi, MD2*, Saurabh Dahiya, MD2, Olga Goloubeva, PhD, MSc2*, Ali Bukhari, MD1, Forat Lutfi, MD1, Gabriela Sanchez-Petitto, MD1, Santanu Samanta, MD3*, Aaron P. Rapoport, MD1, Nancy M. Hardy, MD1, Nicolette Minas, MS2*, Kathleen Ruehle, RN2*, Natalie Gahres, RN2*, Linda Ridge, RN, BA, CCTC2*, Pranshu Mohindra, MD3*, Jason Molitoris, MD3* and Jean A. Yared, MD1

1Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
2University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
3University of Maryland Medical Center, Baltimore, MD

*signifies non-member of ASH